Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chayna Sarkar

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Fundamental & Clinical Pharmacology|July 27, 2006
Medication use for pediatric upper respiratory tract infectionsBiswadeep Das, Chayna Sarkar, Abhijeet Guha Majumder
Cardiovascular Drugs and Therapy|May 24, 2007
Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusionBiswadeep Das, Chayna Sarkar, P Ravi Shankar
Tropical Doctor|March 1, 2007
Medication use in early pregnancy: a study in a teaching hospital in Western NepalChayna Sarkar, Biswadeep Das, Adrija Datta, et al.
Pharmacoepidemiology and Drug Safety|May 8, 2003
A study of drug use during pregnancy in a teaching hospital in western NepalBiswadeep Das, Chayna Sarkar, Adrija Datta, et al.
Pakistan Journal of Pharmaceutical Sciences|January 2, 2008
Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogensBiswadeep Das, Chayna Sarkar, Rakesh Biswas, et al.
Therapeutic Advances in Infectious Disease|June 22, 2017
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensBiswadeep Das, Chayna Sarkar, Debasmita Das, et al.
British Journal of Clinical Pharmacology|July 20, 2019
Cancer chemotherapy drug wastage in a tertiary care hospital in India-A 3-month prospective and 1-year retrospective studyM G Gopisankar, Julie Wahlang, Vikas Jagtap, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease ModelsBiswadeep Das, Chayna Sarkar, Vikram Singh Rawat, et al.
Journal of Family Medicine and Primary Care|November 29, 2023
Assessing the knowledge of medical undergraduates on oral anticoagulation therapyChayna Sarkar, Julie B Wahlang, Reuben P Syiem, et al.
Therapeutic Advances in Drug Safety|March 4, 2017
Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospitalJulie Birdie Wahlang, Purnima Devi Laishram, Dhriti Kumar Brahma, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Fundamental & Clinical Pharmacology|July 27, 2006
Medication use for pediatric upper respiratory tract infectionsBiswadeep Das, Chayna Sarkar, Abhijeet Guha Majumder
Cardiovascular Drugs and Therapy|May 24, 2007
Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusionBiswadeep Das, Chayna Sarkar, P Ravi Shankar
Tropical Doctor|March 1, 2007
Medication use in early pregnancy: a study in a teaching hospital in Western NepalChayna Sarkar, Biswadeep Das, Adrija Datta, et al.
Pharmacoepidemiology and Drug Safety|May 8, 2003
A study of drug use during pregnancy in a teaching hospital in western NepalBiswadeep Das, Chayna Sarkar, Adrija Datta, et al.
Pakistan Journal of Pharmaceutical Sciences|January 2, 2008
Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogensBiswadeep Das, Chayna Sarkar, Rakesh Biswas, et al.
Therapeutic Advances in Infectious Disease|June 22, 2017
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensBiswadeep Das, Chayna Sarkar, Debasmita Das, et al.
British Journal of Clinical Pharmacology|July 20, 2019
Cancer chemotherapy drug wastage in a tertiary care hospital in India-A 3-month prospective and 1-year retrospective studyM G Gopisankar, Julie Wahlang, Vikas Jagtap, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease ModelsBiswadeep Das, Chayna Sarkar, Vikram Singh Rawat, et al.
Journal of Family Medicine and Primary Care|November 29, 2023
Assessing the knowledge of medical undergraduates on oral anticoagulation therapyChayna Sarkar, Julie B Wahlang, Reuben P Syiem, et al.
Therapeutic Advances in Drug Safety|March 4, 2017
Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospitalJulie Birdie Wahlang, Purnima Devi Laishram, Dhriti Kumar Brahma, et al.
Pageof 3